Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Synthetic steroid; glucocorticoid agonist.
Everolimus impurity
Steroid produced by Penicillum; PI3K, mTOR, DNA...
Triazole; 14α demethylase inhibitor.
Ras inhibitor.
Fluoroquinolone; topoisomerase IV, topoisomeras...
Azapirone; α1-adrenergic and 5-HT1A partial ag...
Non-depolarizing NMJ blocker; nAChR antagonist....
JAK2 inhibitor.
Pyrimidine, glucose analog, used to induce diab...
Calcium channel blocker.
PI3K and HDAC inhibitor.
Heterocyclic light-emitting compound, natural l...
Triterpenoid
AhR antagonist.
Endogenous RF-amide peptide, involved in nocice...
Oxazoline; glucocorticoid agonist.
Islet α/β cell proliferation stimulator.
Synthetic steroid hormone; glucocorticoid agoni...
Cardiostimulatory neuropeptide; delayed rectifi...